Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cullen

Showing results (211-220 of 238) with videos related to

Pageof 24
Sort By:
Ambio|November 21, 2018
Global challenges for seagrass conservationRichard K F Unsworth, Len J McKenzie, Catherine J Collier, et al.
Alzheimer'S Research & Therapy|November 23, 2024
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217Branislav Kovacech, Nicholas C Cullen, Petr Novak, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 28, 2024
Study Preregistration: Testing a Digital Suicide Risk Reduction Platform for Adolescents: A Pragmatic Randomized Controlled TrialCarter J Funkhouser, Trinity C Tse, Lauren S Weiner, et al.
Scientific Reports|January 3, 2025
Stakeholder diversity matters: employing the wisdom of crowds for data-poor fisheries assessmentsBenjamin L H Jones, Rolando O Santos, W Ryan James, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 14, 2022
Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patientsRuben Smith, Nicholas C Cullen, Alexa Pichet Binette, et al.
Nature Aging|April 28, 2023
Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinationsNicholas C Cullen, Antoine Leuzy, Sebastian Palmqvist, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 17, 2023
A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase ActivatorJonas M den Heijer, Annelieke C Kruithof, Matthijs Moerland, et al.
Astrobiology|October 20, 2017
Correlations Between Life-Detection Techniques and Implications for Sampling Site Selection in Planetary Analog MissionsDiana M Gentry, Elena S Amador, Morgan L Cable, et al.
Acta Neuropathologica|December 15, 2018
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's diseaseClaudia Cicognola, Gunnar Brinkmalm, Jessica Wahlgren, et al.
JAMA Neurology|December 20, 2021
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer DiseaseAntoine Leuzy, Ruben Smith, Nicholas C Cullen, et al.
Pageof 24

Showing results (211-220 of 238) with videos related to

Sort By:
Pageof 24
Ambio|November 21, 2018
Global challenges for seagrass conservationRichard K F Unsworth, Len J McKenzie, Catherine J Collier, et al.
Alzheimer'S Research & Therapy|November 23, 2024
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217Branislav Kovacech, Nicholas C Cullen, Petr Novak, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 28, 2024
Study Preregistration: Testing a Digital Suicide Risk Reduction Platform for Adolescents: A Pragmatic Randomized Controlled TrialCarter J Funkhouser, Trinity C Tse, Lauren S Weiner, et al.
Scientific Reports|January 3, 2025
Stakeholder diversity matters: employing the wisdom of crowds for data-poor fisheries assessmentsBenjamin L H Jones, Rolando O Santos, W Ryan James, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 14, 2022
Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patientsRuben Smith, Nicholas C Cullen, Alexa Pichet Binette, et al.
Nature Aging|April 28, 2023
Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinationsNicholas C Cullen, Antoine Leuzy, Sebastian Palmqvist, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 17, 2023
A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase ActivatorJonas M den Heijer, Annelieke C Kruithof, Matthijs Moerland, et al.
Astrobiology|October 20, 2017
Correlations Between Life-Detection Techniques and Implications for Sampling Site Selection in Planetary Analog MissionsDiana M Gentry, Elena S Amador, Morgan L Cable, et al.
Acta Neuropathologica|December 15, 2018
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's diseaseClaudia Cicognola, Gunnar Brinkmalm, Jessica Wahlgren, et al.
JAMA Neurology|December 20, 2021
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer DiseaseAntoine Leuzy, Ruben Smith, Nicholas C Cullen, et al.
Pageof 24